Yuuji Murakami

Last Updated :2023/11/02

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medical), Associate Professor
Self-introduction
Radiation oncologist SPECIALITY Development of new techniques in Intensity Modulated Radiation Therapy Chemoradiotherapy for cancer of the digestive system Prediction of the outcomes of radiotherapy using AI & radiomics

Basic Information

Major Professional Backgrounds

  • 1995/05/16, 1996/03/30, Hiroshima University, Medical Hospital, Clinical Resident
  • 1996/04/01, 1998/02/28, Miyoshi Central Hospital, Department of Radiology,, Doctor
  • 1998/03/01, 2002/03/31, Hiroshimma city Asa hospital, Department of Radiology, Doctor
  • 2002/04/01, 2005/03/30, Hiroshima University, Medical Hospital, Clinical Fellow
  • 2005/04/01, 2007/03/31, Hiroshima University, Hospital, Research Associate
  • 2007/04/01, 2011/03/31, Hiroshima University, Hospital, Assistant Professor
  • 2011/04/01, 2019/03/31, Hiroshima University, Graduate School of Biomedical & Health Sciences, Lecturer
  • 2019/04/01, 2021/03/31, Hiroshima University, Graduate School of Biomedical & Health Sciences, Lecturer
  • 2021/04/01, Hiroshima University, Graduate School of Biomedical & Health Sciences, Associate professor

Educational Backgrounds

  • Hiroshima University, Japan, 2003/04, 2007/05
  • Hiroshima University, Faculty of Medicine, Japan, 1988/04, 1995/03

Academic Degrees

  • M.D. Ph.D., Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Medical Physicist
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Radiation science

Research Keywords

  • Prediction of radiotherapy treatment outcomes using radiomics and AI
  • upper and lower digestive cancer
  • chemoradiotherapy
  • volumetric intensity modulated radiation therapy
  • radiotherapy
  • esophageal cancer
  • Head and neck cancer

Affiliated Academic Societies

  • Japanese society of medical oncology, 2020/05
  • American Society for Radiation Oncology

Educational Activity

Course in Charge

  1. 2023, Undergraduate Education, Year, Systemic Disease Control
  2. 2023, Undergraduate Education, Intensive, Practice for medical research
  3. 2023, Undergraduate Education, Intensive, Practice of Medicine I
  4. 2023, Undergraduate Education, Intensive, Practice of Medicine II
  5. 2023, Graduate Education (Master's Program) , First Semester, Research on Radiation Oncology
  6. 2023, Graduate Education (Master's Program) , Second Semester, Research on Radiation Oncology
  7. 2023, Graduate Education (Master's Program) , First Semester, Physics of Diagnostic Radiology
  8. 2023, Graduate Education (Master's Program) , First Semester, Radiation Oncology Physics
  9. 2023, Graduate Education (Master's Program) , Second Semester, Physics of Nuclear Medicine
  10. 2023, Graduate Education (Master's Program) , First Semester, Radiation Oncology
  11. 2023, Graduate Education (Master's Program) , Second Semester, Seminar on Radiation Oncology Physics
  12. 2023, Graduate Education (Master's Program) , Second Semester, Seminar on Radiation Dosimetry
  13. 2023, Graduate Education (Master's Program) , Second Semester, Seminar on Physics of Diagnostic Imaging
  14. 2023, Graduate Education (Master's Program) , First Semester, Seminar on Physics of Nuclear Medicine
  15. 2023, Graduate Education (Master's Program) , Second Semester, Radiation Safety
  16. 2023, Graduate Education (Master's Program) , First Semester, English for Scientific Paper
  17. 2023, Graduate Education (Master's Program) , First Semester, Biostatistics
  18. 2023, Graduate Education (Master's Program) , Second Semester, Health Physics
  19. 2023, Graduate Education (Doctoral Program) , 1Term, Principles of Oncology
  20. 2023, Graduate Education (Doctoral Program) , 1Term, Practice of Oncology
  21. 2023, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Radiation Oncology
  22. 2023, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Radiation Oncology
  23. 2023, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Radiation Oncology
  24. 2023, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Radiation Oncology
  25. 2023, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Radiation Oncology
  26. 2023, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Radiation Oncology
  27. 2023, Graduate Education (Doctoral Program) , First Semester, Initial Radiation Exposure, Internal Exposure, Epidemiology

Research Activities

Academic Papers

  1. Outcome of Hypofractionated Radiotherapy for Localized Gastric Mucosa-associated Lymphoid Tissue Lymphoma, ANTICANCER RESEARCH, 43(8), 3673-3678, 202308
  2. Endoscopic findings suggestive of a high risk of non-radical cure after definitive chemoradiotherapy for cT1bN0M0 esophageal squamous cell carcinoma, ESOPHAGUS, 20(3), 541-547, 202307
  3. Effectiveness of Spacers in Brachytherapy With 198Au Grains for Patients With Buccal Mucosa Cancer, ANTICANCER RESEARCH, 43(5), 2265-2271, 202305
  4. A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10-2 trial), JOURNAL OF RADIATION RESEARCH, 64(1), 154-161, 20230120
  5. Influence of different air CT numbers for IVDT on the dose distribution in TomoTherapy MVCT, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 24(2), 202302
  6. Tolerance levels of mass density for adaptive helical tomotherapy using MVCT, JOURNAL OF RADIATION RESEARCH, 64(1), 195-201, 20230120
  7. Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 28(3), 382-391, 202303
  8. Robust optimization of VMAT for prostate cancer accounting for geometric uncertainty, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 23(9), 202209
  9. Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy, SURGERY, 172(2), 584-592, 202208
  10. Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1), RADIATION ONCOLOGY, 17(1), 20220728
  11. A prediction model for pathological findings after neoadjuvant chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma based on endoscopic images using deep learning, BRITISH JOURNAL OF RADIOLOGY, 95(1135), 202207
  12. Development of a radiomics and machine learning model for predicting occult cervical lymph node metastasis in patients with tongue cancer, ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 134(1), 93-101, 202207
  13. Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 42(5), 2791-2795, 202205
  14. Temporal changes and risk factors for esophageal stenosis after salvage radiotherapy in superficial esophageal cancer following non-curative endoscopic submucosal dissection, RADIOTHERAPY AND ONCOLOGY, 166, 65-70, 202201
  15. Investigating the displacement of radio-active sources during gold-198 grain brachytherapy for hospitalized oral cancer patients, JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 14(2), 115-122, 20220323
  16. Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma, ADVANCES IN RADIATION ONCOLOGY, 2(2), 183-191, 2017
  17. Current update of treatment strategies for borderline resectable pancreatic cancer: a narrative review, JOURNAL OF GASTROINTESTINAL ONCOLOGY, 13(2), 885-897, 202204
  18. Baseline drift vector of multiple points on body surface using a near-infrared camera, PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 45(1), 143-155, 202203
  19. Brachytherapy with Au-198 grains for cancer of the floor of the mouth: relationships between radiation dose and complications, ORAL RADIOLOGY, 38(1), 105-113, 202201
  20. Reirradiation Using Au-198 Grain Brachytherapy for Recurrent Oral Cancer Cases Previously Treated by Definitive Radiotherapy, ANTICANCER RESEARCH, 42(1), 293-300, 202201
  21. Temporal changes and risk factors for esophageal stenosis after salvage radiotherapy in superficial esophageal cancer following non-curative endoscopic submucosal dissection, Radiotherapy and Oncology, 166, 65-70, 20211125
  22. A Prediction Model for Para-Aortic Lymph Node Metastasis in Cervical Cancer by Radiomics Analysis Using Pre-Treatment MRI Images of the Primary Tumor, International Journal of Radiation Oncology*Biology*Physics, 111(3), 20211101
  23. Treatment outcomes of real-time intraoral sonography-guided implantation technique of Au-198 grain brachytherapy for T1 and T2 tongue cancer, JOURNAL OF RADIATION RESEARCH, 62(5), 871-876, 202109
  24. A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning, BRITISH JOURNAL OF RADIOLOGY, 94(1124), 20210708
  25. Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer, LARYNGOSCOPE, 131(7), 1522-1527, 20210701
  26. ★, Predicting the Local Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoradiotherapy by Radiomics with a Machine Learning Method Using F-18-FDG PET Images, DIAGNOSTICS, 11(6), 20210601
  27. Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 28(3), 1798-1807, 20210301
  28. Evaluating Individual Radiosensitivity for the Prediction of Acute Toxicities of Chemoradiotherapy in Esophageal Cancer Patients, RADIATION RESEARCH, 195(3), 244-252, 20210301
  29. Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer, JOURNAL OF RADIATION RESEARCH, 62(2), 300-308, 20210301
  30. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma, JOURNAL OF RADIATION RESEARCH, 62(1), 142-148, 20210101
  31. Evaluation of optimization workflow using custom-made planning through predicted dose distribution for head and neck tumor treatment, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 80, 167-174, 20201201
  32. Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 27(11), 4422-4430, 20201001
  33. What motivated medical students and residents to become radiation oncologists in Japan?-Questionnaire report by the radiotherapy promotion committee of JASTRO, JOURNAL OF RADIATION RESEARCH, 61(5), 727-732, 20200901
  34. A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25(7), 1250-1259, 20200701
  35. A Single Institution's Experience of Definitive Radiotherapy Using Volumetric-modulated Arc Therapy for Hypopharyngeal Cancers, ANTICANCER RESEARCH, 40(7), 4183-4190, 20200701
  36. Risk factors for severe gastrointestinal toxicity in patients receiving palliative radiotherapy for metastatic bone tumors: association with the use of molecular-targeted agents, JOURNAL OF RADIATION RESEARCH, 61(4), 629-634, 20200701
  37. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy using volumetric-modulated arc therapy as an organ preservation approach in patients with stage IVA-B oropharyngeal or hypopharyngeal cancers, JOURNAL OF RADIATION RESEARCH, 61(4), 554-562, 20200701
  38. Effectiveness of salvage radiotherapy for superficial esophageal Cancer after non-curative endoscopic resection, RADIATION ONCOLOGY, 15(1), 20200601
  39. Evaluation of metal artefact techniques with same contrast scale for different commercially available dual-energy computed tomography scanners, PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 43(2), 539-546, 20200601
  40. An overview of stereotactic body radiation therapy for hepatocellular carcinoma, EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 14(4), 271-279, 20200402
  41. Predictive gamma passing rate for three-dimensional dose verification with finite detector elements via improved dose uncertainty potential accumulation model, MEDICAL PHYSICS, 47(3), 1349-1356, 20200301
  42. Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram, JOURNAL OF RADIATION RESEARCH, 61(2), 298-306, 20200301
  43. Is Concurrent Chemotherapy With Radiotherapy for Esophageal Cancer Beneficial in Patients Aged 80 Years or Older?, ANTICANCER RESEARCH, 39(8), 4279-4283, 201908
  44. Clinical Significance of F-18-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 26(6), 1869-1878, 201906
  45. Photon and electron backscatter dose and energy spectrum analysis around Lipiodol using flattened and unflattened beams, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 20(6), 178-183, 201906
  46. Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 39(3), 1433-1440, 201903
  47. Automatic calibration of an arbitrarily-set near-infrared camera for patient surface respiratory monitoring, MEDICAL PHYSICS, 46(3), 1163-1174, 201903
  48. Predictive gamma passing rate by dose uncertainty potential accumulation model, MEDICAL PHYSICS, 46(2), 999-1005, 201902
  49. A novel risk analysis of clinical reference dosimetry based on failure modes and effects analysis, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 58, 59-65, 201902
  50. Development of geometrically ideal dose distribution as a reference for treatment planning in VMAT using filtered back-projection method, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 57, 115-122, 20190101
  51. Evaluation of raw-data-based and calculated electron density for contrast media with a dual-energy CT technique, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 24(5), 499-506, 2019
  52. Medium-term results of intensity modulated radiation therapy for patients with T1-3N0M0 prostate cancer, The journal of the Hiroshima medical association, 71(10), 663-668, 20181028
  53. Evaluation of optimization workflow using design of experiment (DoE) for various field configurations in volumetric-modulated arc therapy, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 54, 34-41, 201810
  54. Clinical features of prostate-specific antigen bounce after I-125 brachytherapy for prostate cancer, JOURNAL OF RADIATION RESEARCH, 59(5), 649-655, 201809
  55. Long-term outcome of stereotactic body radiotherapy for patients with small hepatocellular carcinoma, HEPATOLOGY RESEARCH, 48(9), 701-707, 201808
  56. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies, TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 17, 20180701
  57. Preoperative prediction of a pathologic complete response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy, SURGERY, 164(1), 40-48, 201807
  58. Quantifying esophageal motion during free-breathing and breath-hold using fiducial markers in patients with early-stage esophageal cancer, PLOS ONE, 13(6), 20180611
  59. Curative Criteria After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinomas, DIGESTIVE DISEASES AND SCIENCES, 63(6), 1605-1612, 201806
  60. ★, Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma, Journal of Radiation Research, 59(5), 616-624, 201806
  61. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery, World Journal of Surgery, 5(42), 1496-1505, 201806
  62. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery, WORLD JOURNAL OF SURGERY, 42(5), 1496-1505, 201805
  63. Effect of secondary electron generation on dose enhancement in Lipiodol with and without a flattening filter, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 19(2), 211-217, 201803
  64. Relative biological effectiveness study of Lipiodol based on microdosimetric-kinetic model, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 46, 89-95, 201802
  65. Energy spectrum and dose enhancement due to the depth of the Lipiodol position using flattened and unflattened beams, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 23(1), 50-56, 2018
  66. Interfractional diaphragm changes during breath-holding in stereotactic body radiotherapy for liver cancer, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 23(2), 84-90, 2018
  67. Automatic contrast medium extraction system using electron density data with dual-energy CT, BRITISH JOURNAL OF RADIOLOGY, 91(1090), 2018
  68. Clinical outcomes of concurrent chemoradiotherapy with volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma, JAPANESE JOURNAL OF RADIOLOGY, 35(11), 673-680, 201711
  69. Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer, ANTICANCER RESEARCH, 37(5), 2709-2713, 201705
  70. Evaluation of beam modeling for small fields using a flattening filter-free beam, RADIOLOGICAL PHYSICS AND TECHNOLOGY, 10(1), 33-40, 201703
  71. Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma., Adv Radiat Oncol, 2(2), 183-191, 201702
  72. Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408), JOURNAL OF RADIATION RESEARCH, 58(1), 149-154, 201701
  73. Dosimetric impact of Lipiodol in stereotactic body radiation therapy on liver after trans-arterial chemoembolization, MEDICAL PHYSICS, 44(1), 342-348, 201701
  74. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma, MEDICAL DOSIMETRY, 42(2), 97-103, 2017
  75. Absorbed dose and image quality of Varian TrueBeam CBCT compared with OBI CBCT, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(12), 1628-1633, 201612
  76. Long-term results after 12-year follow-up of patients treated with whole-breast and boost irradiation after breast-conserving surgery, JAPANESE JOURNAL OF RADIOLOGY, 34(9), 595-604, 201609
  77. Availability of applying diaphragm matching with the breath-holding technique in stereotactic body radiation therapy for liver tumors, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(4), 557-561, 201604
  78. Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 21(1), 88-94, 201602
  79. Evaluation of adverse events in atomic bomb survivors receiving curative-intent radiation therapy from 2005 to 2010, RADIOTHERAPY AND ONCOLOGY, 118(1), 60-64, 201601
  80. Preoperative coil embolization in patients with a replaced hepatic artery scheduled for pancreatectomy with splanchnic artery resection helps to prevent ischemic organ injury., Journal of Computer Assisted Tomography, 40(1), 172-176, 201601
  81. Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study, DISEASES OF THE ESOPHAGUS, 29(8), 1115-1120, 2016
  82. Impact of reduction of flux overlap region on kilovoltage cone-beam computed tomography image quality and patients` exposure dose, Reports of Practical Oncology & Radiotherapy, 21(5), 460-465, 2016
  83. Impact of reduction of flux overlap region on kilovoltage cone-beam computed tomography image quality and patients' exposure dose, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 21(5), 460-465, 2016
  84. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(4), 778-787, 20151115
  85. ★, Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20(5), 897-904, 201510
  86. The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma, PLOS ONE, 10(6), 20150611
  87. Results of sequential chemoradiotherapy for intracranial germinoma, JAPANESE JOURNAL OF RADIOLOGY, 33(6), 336-343, 201506
  88. Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer, ANNALS OF THORACIC SURGERY, 99(6), 1887-1893, 201506
  89. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies, HEPATOLOGY RESEARCH, 45(4), 378-386, 201504
  90. Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy, JOURNAL OF RADIATION RESEARCH, 56(2), 315-324, 201503
  91. Case reports of portal vein thrombosis and bile duct stenosis after stereotactic body radiation therapy for hepatocellular carcinoma, HEPATOLOGY RESEARCH, 44(10), E273-E278, 201410
  92. Time-Adjusted Internal Target Volume: A Novel Approach Focusing on Heterogeneity of Tumor Motion Based on 4-Dimensional Computed Tomography Imaging for Radiation Therapy Planning of Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 89(5), 1129-1137, 20140801
  93. Radiation-induced pyogenic vertebral osteomyelitis after re-irradiation for para-aortic lymph node metastases in a patient with cervical cancer, International Cancer Conference Journal, 3(4), 207-210, 2014
  94. Dynamic computed tomography appearance of tumor response after stereotactic body radiation therapy for hepatocellular carcinoma: How should we evaluate treatment effects?, HEPATOLOGY RESEARCH, 43(7), 717-727, 201307
  95. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 69(6), 1499-1505, 201206
  96. ★, Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 17(3), 263-271, 201206
  97. Functional Image-Guided Radiotherapy Planning in Respiratory-Gated Intensity-Modulated Radiotherapy for Lung Cancer Patients With Chronic Obstructive Pulmonary Disease, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(4), E663-E670, 20120315
  98. Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 17(1), 48-54, 201202
  99. Six-year experience of permanent prostate brachytherapy for clinically localized prostate cancer., Hiroshima Journal of Medical Science, 60(4), 51-56, 20111201
  100. Evaluation of adverse events in atomic bomb survivors receiving curative-intent radiation therapy from 2005 to 2010, Radiother Oncol., 118(1), 60-64, 2010
  101. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix., Int J Radiat Oncol Biol Phys, 75(2), 369-377, 20091001
  102. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001., Int J Radiat Oncol Biol Phys., 75(2), 357-363, 20091001
  103. Results of a preliminary study using hypofractionated involved field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced Non-Small-Cell lung cancer, Int J Clin Oncol,, 14(5), 408-415, 20091001
  104. Results of the 1999-2001 Japanese Patterns of Care Study for Patients Receiving Defintive Radiation Theraphy without Surgery for Esophageal Cancer, Japanese journal of clinical oncology, 37(7), 493-500, 20070723
  105. ★, Evaluation of the basic properties of the BANGkitTM gel dosimeter, Physics in Medicine and Biology, 52(8), 2301-2311, 20070403
  106. ★, Evaluation of the basic properties of the BANGkit? gel dosimeter, Physics in Medicine and Biology= Institute of Physics, 52, 2301-2311, 20070403
  107. Preoperative portal vein embolization with a mixture of gelatin sponge and lodized oil: Efficacy and safety, Acta Radiologica, 47(10), 1022-1028, 20061201
  108. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers?, International radiation oncology biology and physics, 66(2), 483-491, 20061001
  109. Diffuse cerebral white matter T2-weighted hyperintensity: a new finding of general paresis., Acta Radiologica, 47, 609-611, 20060701
  110. Potential benefits of volumetric modulated arc therapy to reduce the incidence of >= grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(12), 1729-1735, 202112

Publications such as books

  1. 2020/09, Guideline for radiotherapy treatment planning, 2020, September, Textbook, Joint work, 日本語, ISBN: 9784307071161, 440, 139-144
  2. 2016/09/15, Guideline for radiotherapy treatment planning, 2016, September, Textbook, Joint work, 日本語, 978-4-307-07104-8, 408, 119-123

External Funds

Acceptance Results of Competitive Funds

  1. Practical Research for Innovative Cancer Control, 2015/04/01, 2016/03/31
  2. KAKENHI, 2014, 2016
  3. KAKENHI, Development of Functional Image-Guided Radiotherapy Planning inIntensity-Modulated Radiation Therapy (IMRT) for Lung Cancer, 2010, 2012
  4. KAKENHI, Development of a new Stereotactic Body Radiation Therapy (SBRT) and Intensity Modulated Radiation therapy (IMRT) technique using an integrated Image Guide Radiation Therapy (IGRT) system, 2010, 2012
  5. KAKENHI, 2009, 2010
  6. Health and Labour Sciences Research Grants, 2014/05/01, 2015/03/31
  7. KAKENHI, 2015, 2018
  8. Practical Research for Innovative Cancer Control , 2016/04/01, 2017/03/31
  9. KAKENHI(Grant-in-Aid for Scientific Research (C)), 2019/04/01, 2021

Social Activities

Organizing Academic Conferences, etc.

  1. 2022/11, 2022/11
  2. 2021/03, 2021/03
  3. IAEA/RCA Regional Training Course, Faculty member, 2015/01, 2015/01
  4. 2012/07
  5. 2012/07
  6. 2003/04

Other Social Contributions

  1. 2019 Health Science Symposium with Taichung Veterans General Hospital, Current Status of Radiotherapy for Esophageal Squamous Cell Carcinoma in Japan, 2019/07/26, Hiroshima Japan, Lecturer, Meeting or assembly, Researchesrs
  2. HICARE-IAEA seminar, IMRT for Localized Prostate Cancer, HICARE-IAEA, 2019/02/18, Hiroshima Japan, Lecturer, Seminar or workshop, Researchesrs
  3. Preceptorship in HNC, Current status of Multidisciplinary Team for head and neck cancer patients, 2018/11/23, Lecturer, Seminar or workshop, Researchesrs

History as Peer Reviews of Academic Papers

  1. 2022, International journal of clinical oncology, Others, reviewer, 1
  2. 2022, biomeditics, Others, reviewer, 1
  3. 2022, Esophagus, Others, reviewer, 2
  4. 2022, Journal of radiation research, Others, reviewer, 3
  5. 2020, JOrunal of radiation research, Others, reviewer, 2
  6. 2020, Esophagus, Others, Reviewer, 1
  7. 2020, Japanese journal of clinical oncology, Others, Reviewer, 1
  8. 2016, The journal of radiation research, Others, reviewer, 8
  9. 2016, Radiation Oncology, Others, reviewer, 1
  10. 2015, The Journal of Radiation Research, Others, Reviewer, 2
  11. 2014, The Journal of Radiation Research, Others, Reviewer, 3